First human test for new anesthesia reversal drug
NCT ID NCT07195604
Summary
This is an early-stage study to test the safety of a new injection called HRS-2162. The drug is designed to help patients regain muscle control after surgery when they are given paralyzing anesthesia. The study will enroll 64 healthy volunteers to see how their bodies handle a single dose and to check for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REVERSAL OF NEUROMUSCULAR BLOCKADE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sichuan Academy of Medical Sciences &Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, 610072, China
Contact
Conditions
Explore the condition pages connected to this study.